Safety and Efficacy of Mitapivat in Pyruvate Kinase DeficiencyRachael F. Grace, Bertil Glader, Wilma Barcellini et al.|New England Journal of Medicine|2019Cited by 162
Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK StudyRachael F. Grace, Bertil Glader, D. Mark Layton et al.|Blood|2019Cited by 3